99 related articles for article (PubMed ID: 8659199)
41. The effect of isosorbide dinitrate on uterine and ovarian blood flow in cycling and early pregnant mares: A pilot study.
Zoller D; Lüttgenau J; Steffen S; Bollwein H
Theriogenology; 2016 Jun; 85(9):1562-1567. PubMed ID: 26879997
[TBL] [Abstract][Full Text] [Related]
42. Time-of-day variation in cardiovascular response to maximal exercise testing in coronary heart disease patients taking a beta-blocker.
Dufour Doiron M; Prud'homme D; Boulay P
Appl Physiol Nutr Metab; 2007 Aug; 32(4):664-9. PubMed ID: 17622280
[TBL] [Abstract][Full Text] [Related]
43. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
44. [Intermittent claudication induced by betablocker: what to do?].
Stiegler H
MMW Fortschr Med; 2009 Aug; 151(34-35):45-6. PubMed ID: 19771791
[No Abstract] [Full Text] [Related]
45. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
Strein K; Sponer G
Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054
[TBL] [Abstract][Full Text] [Related]
46. Effect of felodipine on regional blood supply and collateral vascular resistance in patients with peripheral arterial occlusive disease.
Liu Y; Opitz-Gress A; Rott A; Liewald F; Sunder-Plassmann L; Lehmann M; Stauch M; Steinacker JM
Vasc Med; 1997; 2(1):13-8. PubMed ID: 9546944
[TBL] [Abstract][Full Text] [Related]
47. Dobutamine effect on ankle-brachial pressure index in patients with peripheral arterial occlusive disease. New noninvasive test for evaluation of peripheral circulation?
Wysokinski WE; Spittell PC; Pellikka PA; Miller WL; Seward JB
Int Angiol; 1998 Sep; 17(3):201-7. PubMed ID: 9821035
[TBL] [Abstract][Full Text] [Related]
48. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol.
Cleophas TJ; van der Mey N; van der Meulen J; Niemeyer MG
Int J Clin Pharmacol Ther; 1996 Jul; 34(7):312-7. PubMed ID: 8832309
[TBL] [Abstract][Full Text] [Related]
49. Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril.
Di Mario C; Strikwerda S; Gil R; Azar A; Rames A; Serruys PW
Ital Heart J; 2000 Oct; 1(10):674-83. PubMed ID: 11061364
[TBL] [Abstract][Full Text] [Related]
50. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
51. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
52. [Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Chotchaev KhKh; Naumov VG
Klin Med (Mosk); 2000; 78(9):52-5. PubMed ID: 11051743
[TBL] [Abstract][Full Text] [Related]
53. [Conservative therapy of coronary disease].
Kaltenbach M
Dtsch Med Wochenschr; 1976 Feb; 101(6):208-13. PubMed ID: 2455
[No Abstract] [Full Text] [Related]
54. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials.
Radack K; Deck C
Arch Intern Med; 1991 Sep; 151(9):1769-76. PubMed ID: 1679624
[TBL] [Abstract][Full Text] [Related]
55. Phosphorus magnetic resonance spectroscopy: a noninvasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy.
Wahl DG; Simon JP; Robin B; Walker P; Jouanny P; Escanye JM; Paille F; Schmidt C; Brunotte F; Robert J
Angiology; 1994 May; 45(5):367-76. PubMed ID: 8172384
[TBL] [Abstract][Full Text] [Related]
56. [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
Klinger D
Wien Med Wochenschr; 1987 Jun; 137(12):278-86. PubMed ID: 2887073
[TBL] [Abstract][Full Text] [Related]
57. [Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease].
Streminski JA; de la Haye R; Rettig K; Kuntz G
Vasa; 1992; 21(4):392-402. PubMed ID: 1485475
[TBL] [Abstract][Full Text] [Related]
58. [MR-Imaging of lower leg muscle perfusion].
Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
[TBL] [Abstract][Full Text] [Related]
59. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study.
Brevetti G; Perna S; Sabbà C; Rossini A; Scotto di Uccio V; Berardi E; Godi L
Eur Heart J; 1992 Feb; 13(2):251-5. PubMed ID: 1555624
[TBL] [Abstract][Full Text] [Related]
60. Medical treatment of peripheral vascular disease: good or bad?
Duprez D; Clement DL
Eur Heart J; 1992 Feb; 13(2):149-51. PubMed ID: 1555609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
